Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

HAE
Haemonetics Corporation
stock NYSE

Market Open
Aug 11, 2026 12:38:13 PM EDT
87.55USD+1.132%(+0.98)159,318
75.83Bid   100.32Ask   24.49Spread
Pre-market
0.00USD-100.000%(-87.84)0
After-hours
Aug 10, 2026 4:10:30 PM EDT
86.61USD+0.046%(+0.04)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsMore
open chart   
open chart   
Market Cap
3.98B
CEO
Christopher Simon
Headquarters
Boston, Massachusetts, USA
Industry
Medical Instruments & Supplies
Last Split
Dec 3, 20122for1
Related
CERSBAXBDXJNJSYKTMOPKIMDTXLV
HAE Stats
Avg. Vol. 10 Day
901,615
Avg. Vol. 30 Day
707,388
Employees
3,136
Market Cap
3,983,266,815
Shares Out.
45,497,051
On/Off Exchange
55%/45%
6 Month Beta
0.36
1 Year Beta
0.20
2 Year Beta
0.58
3 Year Beta
0.62
52 Week Low
47.32
52 Week High
88.59
SMA50
77.07
SMA200
68.71
1 Week
+2.54%
1 Month
+14.91%
3 Month
+67.59%
6 Month
+52.26%
1 Year
+66.86%
2 Year
+17.27%
5 Year
+41.28%
Profile
haemonetics is the blood management company. our comprehensive portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood management continuum. collectively they help improve patient care, ensure patient safety, and reduce costs for blood and plasma collectors, hospitals, and patients around the world. our mission we believe that through proper blood management, our products and services can help our commercial plasma and blood center customers optimize their collection processes. we seek to help ensure a continual supply of high-quality plasma for biopharmaceuticals and blood components for therapeutic use at optimal costs, along with better blood management processes. working with our hospital customers, we seek to prevent a blood transfusion to the patient who doesn't need one, or, if a transfusion is necessary, to ensure the transfusion of the right blood product, at the right time, in the right

HAE Stock Summary

Haemonetics Corporation (NYSE:HAE) stock price today is $87.55, and today's volume is 159,318. HAE is up 1.132% today. The 30 day average volume is 707,388. HAE market cap is 3.98B with 45,497,051 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC